Compare Canadian Pacific Kansas City Limited Common Shares (CP) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian Pacific Kansas City Limited Common Shares vs Citius Pharmaceuticals Inc — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $84.17 (market cap $73.98B), while Citius Pharmaceuticals Inc trades at $0.49 (market cap $13.62M). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 5431.7× Citius Pharmaceuticals Inc's market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.9% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CP | CTXR | |
|---|---|---|
Market Cap | $73.98B | $13.62M |
Volume | 1,669,828 | 132,438 |
Sector | Industrials | Health |
52-Week High | $96.69 | $1.82 |
52-Week Low | $68.88 | $0.48 |
Enterprise Value | $91.36B | $3.79M |
Dividend Yield | 0.9% | — |
Typical Hold Time | — | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CTXR trades at $0.5082, up 5.72% today, amid a bearish technical trend but with oversold oscillators suggesting potential for a near-term bounce. The company reported its first revenue of $7 million in 2026 from LYMPHIR sales, yet remains deeply unprofitable with a net income margin of -651.27%. Analyst consensus is strongly positive with five buy ratings and a $5.00 price target, highlighting optimism around its oncology drug launch despite significant cash burn from operations.
The outlook hinges on successful commercialization of LYMPHIR to offset steep losses. Investment opportunity lies in the drug's market adoption and analyst bullishness, but risks include sustained negative cash flow, execution challenges, and the stock's high volatility. Shareholder value depends on translating revenue growth into profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Canadian Pacific Kansas City Limited Common Shares
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
